NASDAQ NMS - GLOBAL MARKET · BMRN

+2.02% · +$1.17 · Vol Not reported

Market closed · last close 4:00 PM ET · price as of 16:00:00 ET

BioMarin Pharmaceutical Inc

Biotechnology

$58.99

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

REFRESHES DAILY

AI Analysis

Sovereign

Why is BMRN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

About BioMarin Pharmaceutical Inc

PHARMACEUTICAL PREPARATIONS

Listed since

1999

Employees

Country

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$58.52

Day high

$59.43

Day low

$58.10

Previous close

$57.82

52W high

$59.43

-0.74% from high

52W low

$54.69

91% of range

Market cap

$11.4B

P/E

42.43×

EPS

$2.56

Shares out

193.3M

VWAP

$57.82

Last session

Price history computed in-house

+0.08%

SMA 50 $56.83 · above

SMA 200 $56.83 · above

52W position 91%

Veridion warehouse edge

Warehouse intelligence for BMRN.

Veridion Score

0: 741: 472: 523: 504: 785: Not reported

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

BMRN insider activity

BioMarin Pharmaceutical Inc

Score

Coverage building

Pressure

Net selling

Filings

Buys / sells

3 / 17

Net value

-$6.7M

Insiders

Named filers

Hubbard Cristin

Insider

Leadership

Friberg Gregory R

Insider

Leadership

Davis George Eric

Insider

Leadership

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$6.7M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-05-21	2026-05-20	Hubbard Cristin	Insider	sell	$50.20	2,318	42,472	$116K	SEC Form 4
2026-05-11	2026-05-07	Friberg Gregory R	Insider	sell	$53.85	3,281	51,818	$177K	SEC Form 4
2026-03-19	2026-03-18	Davis George Eric	Insider	sell	$56.05	1,273	78,560	$71K	SEC Form 4
2026-03-19	2026-03-17	Guyer Charles Greg	Insider	sell	$56.05	1,693	84,140	$95K	SEC Form 4
2026-03-19	2026-03-17	Mueller Brian	Insider	sell	$56.05	2,117	123,314	$119K	SEC Form 4

Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 15 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

BMRN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for BMRN in this window.

Lobbying spend

BMRN lobbying filings, year to date.

Registered lobbying filings matched to BioMarin Pharmaceutical Inc.

$1.1M

Refresh interval: 12hSource: LDA disclosure filings

Health IssuesBudget/Appropriations Health Issues Medicare/Medicaid Tariff (miscellaneous tariff bills) Taxation/Internal Revenue CodeMedicare/Medicaid Pharmacy

Filing

$530.0K

BIOMARIN PHARMACEUTICAL INC.

Apr 20, 2026

Filing

$390.0K

BIOMARIN PHARMACEUTICAL INC.

Jan 20, 2026

Filing

$50.0K

BIOMARIN PHARMACEUTICAL INC.

BGR GOVERNMENT AFFAIRS